- Home
- RSLS vs PRSO Comparison
RSLS vs PRSO Comparison
Compare RSLS & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- PRSO
- Stock Information
- Founded
- RSLS 2002
- PRSO 2008
- Country
- RSLS United States
- PRSO United States
- Employees
- RSLS N/A
- PRSO N/A
- Industry
- RSLS Medical/Dental Instruments
- PRSO Semiconductors
- Sector
- RSLS Health Care
- PRSO Technology
- Exchange
- RSLS Nasdaq
- PRSO Nasdaq
- Market Cap
- RSLS 4.5M
- PRSO 4.3M
- IPO Year
- RSLS 2007
- PRSO 2001
- Fundamental
- Price
- RSLS $2.56
- PRSO $1.10
- Analyst Decision
- RSLS Hold
- PRSO Strong Buy
- Analyst Count
- RSLS 1
- PRSO 1
- Target Price
- RSLS N/A
- PRSO $3.00
- AVG Volume (30 Days)
- RSLS 7.3M
- PRSO 349.0K
- Earning Date
- RSLS 08-13-2025
- PRSO 08-11-2025
- Dividend Yield
- RSLS N/A
- PRSO N/A
- EPS Growth
- RSLS N/A
- PRSO N/A
- EPS
- RSLS N/A
- PRSO N/A
- Revenue
- RSLS $7,175,000.00
- PRSO $15,626,000.00
- Revenue This Year
- RSLS $52.80
- PRSO $3.96
- Revenue Next Year
- RSLS N/A
- PRSO $36.80
- P/E Ratio
- RSLS N/A
- PRSO N/A
- Revenue Growth
- RSLS N/A
- PRSO 35.50
- 52 Week Low
- RSLS $2.23
- PRSO $0.52
- 52 Week High
- RSLS $414.99
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- RSLS 36.91
- PRSO 51.24
- Support Level
- RSLS $2.45
- PRSO $1.09
- Resistance Level
- RSLS $2.87
- PRSO $1.31
- Average True Range (ATR)
- RSLS 0.68
- PRSO 0.16
- MACD
- RSLS 0.14
- PRSO -0.01
- Stochastic Oscillator
- RSLS 5.45
- PRSO 27.87
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.